Primary and substance-induced psychotic disorders in methamphetamine users

Psychiatry Research

Volumn 226, Issue 1, 2015, Pages 91-96

  Hides, Leanne ^a   Dawe, Sharon ^b   McKetin, Rebecca ^b,c   Kavanagh, David J ^a   Young, Ross McD ^a   Teesson, Maree ^d   Saunders, John B ^e,f  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

^c AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e UNIVERSITY OF QUEENSLAND   (Australia)

^f University of Sydney   (Australia)

Author keywords

Diagnosis; Drug use disorder; Methamphetamine; Psychosis; Substance induced

Indexed keywords

METHAMPHETAMINE;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; DSM-IV; FEMALE; HEALTH CARE ACCESS; HEALTH PROGRAM; HUMAN; MALE; MENTAL HEALTH SERVICE; NEUROPSYCHOLOGICAL TEST; ONSET AGE; PRIMARY PSYCHOTIC DISORDER; PRIORITY JOURNAL; PSYCHIATRIC RESEARCH INTERVIEW FOR DSM IV SUBSTANCE AND MENTAL DISORDER; PSYCHOSIS; SUBSTANCE ABUSE; SUBSTANCE INDUCED PSYCHOTIC DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG ABUSE; PSYCHOLOGY; PSYCHOSES, SUBSTANCE-INDUCED; PSYCHOTIC DISORDERS; SYMPTOM ASSESSMENT; YOUNG ADULT;

ADULT; AGE OF ONSET; AMPHETAMINE-RELATED DISORDERS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; METHAMPHETAMINE; PSYCHOSES, SUBSTANCE-INDUCED; PSYCHOTIC DISORDERS; SYMPTOM ASSESSMENT; YOUNG ADULT;

EID: 84926212842     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2014.11.077     Document Type: Article

References (27)

1. Ali R., Marsden J., Srisurapanont M., Agueda S., Baigent M., Monteiro M. Methamphetamine psychosis in Australia, Philippines, and Thailand: recommendations for acute care and clinical inpatient management. Addictive Disorders and Their Treatment 2010, 9:143-149.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) 2013, APA, Arlington, VA.
3. Caton C.L., Drake R.E., Hasin D.S., Dominguez B., Shrout P.E., Samet S., Schanzer W.B. Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychoses. Archives of General Psychiatry 2005, 62:137-145.
4. Chen C., Lin S., Sham P., Ball D., Loh E., Murray R. Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis. American Journal of Medical Genetics. B. Neuropsychiatric Genetics 2005, 136:87-91.
5. Chen C.K., Lin S.K., Sham P.C., Ball D., Loh E.W., Hsiao C.C., Chiang Y.L., Ree S.C., Lee C.H., Murray R. Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Psychological Medicine 2003, 33:1407-1414.
6. Colfax G., Santos G.-M., Chu P., Vittinghoff E., Pluddemann A., Kumar S., Hart C. Amphetamine-group substances and HIV. The Lancet 2010, 376:458-474.
7. Fals Stewart W., O'Farrell T.J., Freitas T.T., McFarlin S.K., Rutigliano P. The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties. Journal of Consulting and Clinical Psychology 2000, 68:134-144.
8. Fraser S., Hides L., Phillips L.J., Proctor D., Lubman D.I. Differentiating substance-induced from primary psychotic disorders with comorbid substance use in first episode psychosis. Schizophrenia Research 2012, 136:110-115.
9. Glasner-Edwards S., Mooney L.J., Marinelli-Casey P., Hillhouse M., Ang A., Rawson R., Methamphetamine Treatment Project Corporate Authors Clinical course and outcomes of methamphetamine-dependent adults with psychosis. Journal of Substance Abuse Treatment 2008, 35:445-450.
10. Gossop M., Darke S., Griffiths P., Hando J. The severity of dependence scale (SDS): Psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 1995, 90:607-614.
11. Hall W., Hando J. Route of administration and adverse effects of amphetamine use in Sydney, Australia. Addiction 1994, 88:509-516.
12. Hall W., Hando J., Darke S., Ross J. Psychological morbidity and route of administration among amphetamine users in Sydney, Australia. Addiction 1996, 91:81-87.
13. Hasin D., Trautman K.D., Miele G.M., Samet S., Smith M., Endicott J. Psychiatric research interview for substance and mental disorders (PRISM): reliability for substance abusers. American Journal of Psychiatry 1996, 153:1195-1201.
14. Hosmer D.W., Lemeshow S. Applied Logistic Regression 2005, Wiley, London.
15. Kittirattanapaiboon P., Mahatnirunkul S., Booncharoen H., Thummawomg P., Dumrongchai U., Chutha W. Long-term outcomes in methamphetamine psychosis patients after first hospitalisation. Drug and Alcohol Review 2010, 29:456-461.
16. Lecrubier Y., Sheehan D.V., Weiller E., Amorim P., Bonara I., Sheehan K.H., Janavs J., Dunbar G.C. The mini international neuropsychiatric interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. European Psychiatry 1997, 12.
17. Lukoff D., Liberman R.P., Nuechterlein K.H. Symptom monitoring in the rehabilitation of schizophrenia patients. Schizophrenia Bulletin 1986, 12:258-593.
18. McKetin R., Hickey K., Devlin K., Lawrence K. The risk of psychotic symptoms associated with recreational methamphetamine use. Drug and Alcohol Review 2010, 29:358-363.
19. McKetin R., Lubman D., Baker A.L., Dawe S., Ali R. Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study. Archives of General Psychiatry 2013, 70:319-324.
20. McKetin R., McLaren J., Lubman D.I., Hides L. The prevalence of psychotic symptoms among methamphetamine users. Addiction 2008, 17:235-240.
21. McKetin R., Najman J.M., Baker A.L., Lubman D.I., Dawe S., Ali R., Lee N.K., Mattick R.P., Mamun A. Evaluating the impact of community-based treatment options on methamphetamine use: findings from the Methamphetamine Treatment Evaluation Study (MATES). Addiction 2012, 107:1998-2008.
22. Medhus S., Mordal J., Holm B., Morland J., Bramness J.G. A comparison of symptoms and drug use between patients with methamphetamine associated psychoses and patients diagnosed with schizophrenia in two acute psychiatric wards. Psychiatry Research 2013, 206:17-21.
23. Salo R., Flower K., Kielstein A., Leamon M.H., Nordahl T.E., Galloway G.P. Psychiatric comorbidity in methamphetamine dependence. Psychiatry Research 2011, 186:356-361.
24. Swift W., Copeland J., Hall W. Choosing a diagnostic cut-off for cannabis dependence. Addiction 1998, 93:1681-1692.
25. Topp L., Mattick R.P. Choosing a cut-off on the Severity of Dependence Scale (SDS) for amphetamine users. Addiction 1997, 92:839-845.
26. Torrens M., Serrano D., Astais M., Pérez-Domínguez G., Martín-Santos R. Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV. American Journal of Psychiatry 2004, 161:1231-1237.
27. Ventura J., Nuechterlein K.H., Subotnik K.L., Gutkind D., Gilbert E.A. Symptom dimensions in recent-onset schizophrenia and mania: a principal components analysis of the 24-item Brief Psychiatric Rating Scale. Psychiatry Research 2000, 97:129-135.